Seeing is believing: No therapy for glaucoma? Focus on “role of nitric oxide in murine conventional outflow physiology”

American Journal of Physiology - Cell Physiology

Volumn 309, Issue 4, 2015, Pages C203-C204

  Rogers, Natasha M ^a,b   Isenberg, Jeffrey S ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; NITRIC OXIDE; PROSTAGLANDIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

AQUEOUS HUMOR FORMATION; AQUEOUS HUMOR OUTFLOW; CARDIOVASCULAR DISEASE; EDITORIAL; EYE DISEASE; HUMAN; NONHUMAN; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; TRABECULAR MESHWORK; ANIMAL; AQUEOUS HUMOR; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; METABOLISM; PHYSIOLOGY;

MURINAE;

ANIMALS; AQUEOUS HUMOR; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84939500554     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00180.2015     Document Type: Editorial

References (10)

1. Awadalla MS, Thapa SS, Hewitt AW, Craig JE, Burdon KP. Association of eNOS polymorphisms with primary angle-closure glaucoma. Invest Ophthalmol Vis Sci 54: 2108–2114, 2013.
2. Carta F, Supuran CT, Scozzafava A. Novel therapies for glaucoma: a patent review 2007–2011. Expert Opin Ther Patents 22: 79–88, 2012.
3. Chang JY, Stamer WD, Bertrand J, Read AT, Marando CM, Ethier CR, Overby DR. Role of nitric oxide in murine conventional outflow physiology. Am J Physiol Cell Physiol (June 3, 2015). doi:10.1152/ajpcell.00347.2014.
4. Ellis DZ. Guanylate cyclase activators, cell volume changes and IOP reduction. Cell Physiol Biochem 28: 1145–1154, 2011.
5. Klein R, Klein BE. The prevalence of age-related eye diseases and visual impairment in aging: current estimates. Invest Ophthalmol Vis Sci 54: ORSF5–ORSF13, 2013.
6. Lee AJ, Wang JJ, Kifley A, Mitchell P. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology 113: 1069–1076, 2006.
7. Nathanson JA, McKee M. Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci 36: 1765–1773, 1995.
8. Paneni F, Costantino S, Cosentino F. Molecular pathways of arterial aging. Clin Sci (Lond) 128: 69–79, 2015.
9. Ridnour LA, Thomas DD, Donzelli S, Espey MG, Roberts DD, Wink DA, Isenberg JS. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Signal 8: 1329–1337, 2006.
10. Wizemann AJ, Wizemann V. Organic nitrate therapy in glaucoma. Am J Ophthalmol 90: 106–109, 1980.